Firefly Neuroscience, Inc.
PublicFirefly Neuroscience, Inc. is now publicly traded
The data on this page reflects Firefly Neuroscience, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Mar 13, 2026
Total Funding Raised
$2.25M
Company Overview
Firefly Neuroscience, Inc. is a medical technology and AI company that provides an FDA-cleared Brain Network Analytics (BNA™) software platform to improve outcomes for patients with mental illnesses and neurological disorders.
AI Layer
Application
Keywords
Firefly Neuroscience, Inc. Comparables
Compare Firefly Neuroscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mentis Cura | 74% | |
| Vistim Labs | 74% | |
| Universal Brain | 71% |
Firefly Neuroscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Mar 13, 2026 |
Key People
Founding team and executive leadership
Recent news
Latest coverage and updates
- partners_withSep 25, 2026
Firefly Neuroscience, Inc. partnered with NeuroSigma, Inc. on Jan 1st '24.
- partners_withSep 17, 2026
Firefly Neuroscience, Inc. partnered with Radial Health, Inc. on Sep 17th '26.
Firefly Neuroscience, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access